Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma
Clinical and Molecular Hepatology · 2024
DOI: 10.3350/cmh.2024.0042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, 2024. Verfasst von Jiwon Hong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Molecular Biology, Ajou University School of Medicine, Suwon, Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Research Foundation of Korea, Korea Health Industry Development Institute, Ministry of Health and Welfare.
Abstract (Originalsprache)
Background/Aims: Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality worldwide. Despite identification of several biomarkers for HCC diagnosis, challenges such as low sensitivity and intratumoral heterogeneity have impeded early detection, highlighting the need for etiology-specific blood biomarkers.
Methods
We generated whole-transcriptome sequencing (WTS) and targeted proteome data from buffy coat and plasma samples from HCC patients. By integrating etiological information on viral infection, we investigated the etiology-specific gene expression landscape at the blood level. Validation of differentially expressed genes (DEGs) was performed using publicly available RNA-seq datasets and qRT‒PCR with AUC analyses.
Results
Differential expression analyses with multiomics data revealed distinct gene expression profiles between HBV-associated HCC and nonviral HCC, indicating the presence of etiology-specific blood biomarkers. The identified DEGs were validated across multiple independent datasets, underscoring their utility as biomarkers. Additionally, single-cell RNA-seq analysis of HCC confirmed differences in DEG expression across distinct immune cell types.
Conclusions
Our buffy coat WTS data and plasma proteome data may serve as reliable sources for identifying etiology-specific blood biomarkers of HCC and might contribute to discovery of therapeutic targets for HCC across different etiologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry & Molecular Biology, Ajou University School of Medicine, Suwon, Korea.
- Department of Biomedical Sciences, Graduate School of Ajou University, Suwon, Korea.
- Department of Gastroenterology, Ajou University School of Medicine, Suwon, Korea.
Förderung
- National Research Foundation of Korea
- Korea Health Industry Development Institute
- Ministry of Health and Welfare
- Ministry of Science and ICT
Zitieren
APA
Hong, J., Eun, J. W., Baek, G. O., Cheong, J. Y., Park, S., Kim, S. S., Cho, H. J., & Lim, S. B. (2024). Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2024.0042
Vancouver
Hong J, Eun JW, Baek GO, Cheong JY, Park S, Kim SS, et al. Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma. Clinical and Molecular Hepatology. 2024. doi:10.3350/cmh.2024.0042
BibTeX
@article{Hong2024,
author = {Hong, Jiwon and Eun, Jung Woo and Baek, Geum Ok and Cheong, Jae Youn and Park, Seryoung and Kim, Soon Sun and Cho, Hyo Jung and Lim, Su Bin},
title = {Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma},
journal = {Clinical and Molecular Hepatology},
year = {2024},
doi = {10.3350/cmh.2024.0042}
}
EUVIMED